Grifols S. A.

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:IBEX_35_index
gptkbp:acquisition gptkb:Alkahest
gptkb:Giga_Gen
gptkb:Progenika_Biopharma
gptkb:Biotest_AG
gptkb:Talecris_Biotherapeutics
gptkbp:ceo gptkb:Victor_Grifols_Deu
gptkbp:employees over 24,000
gptkbp:founded gptkb:1940
gptkbp:founder gptkb:Victor_Grifols_Roura
gptkbp:headcount over 24,000
gptkbp:headquarters gptkb:Barcelona,_Spain
https://www.w3.org/2000/01/rdf-schema#label Grifols S. A.
gptkbp:industry gptkb:drug
gptkbp:market_cap €10 billion (2021)
gptkbp:partnership gptkb:University_of_Barcelona
gptkb:University_of_California,_Merced
gptkb:University_of_California,_Santa_Cruz
gptkb:University
gptkb:Harvard_University
gptkb:University_of_California
gptkb:University_of_California,_Irvine
gptkb:University_of_California,_Los_Angeles
gptkb:University_of_California,_San_Francisco
gptkb:University_of_Michigan
gptkb:University_of_Pittsburgh
gptkb:University_of_Toronto
gptkb:University_of_Washington
gptkb:University_of_California,_Davis
gptkb:University_of_California,_San_Diego
gptkb:University_of_Melbourne
gptkb:University_of_Queensland
gptkb:University_of_Sydney
gptkb:University_of_California,_Riverside
gptkb:University_of_Texas
gptkb:University_of_New_South_Wales
gptkb:Cleveland_Clinic
gptkb:University_of_Alberta
gptkb:University_of_California,_Santa_Barbara
gptkb:University_of_California,_San_Francisco_Bay_Area
gptkbp:product_line albumin
IVIG
coagulation factors
hyperimmune globulins
gptkbp:products plasma-derived medicines
gptkbp:region Worldwide
gptkbp:research_focus immunology
gptkbp:revenue €5.3 billion (2020)
gptkbp:stock_exchange gptkb:NASDAQ
gptkbp:subsidiary gptkb:Grifols_Biologicals
gptkb:Grifols_Diagnostic_Solutions
gptkbp:type gptkb:Company
gptkbp:website www.grifols.com